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Pharmacological Implications of A2Ar-D2R Heteromerization and the Sig-
nificance for Parkinson’s Disease
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Physiology and Biophysics, Virginia Commonwealth University, Richmond,
VA, USA.
Background: Recently, heteromeric GPCR complexes have become attractive
targets for drug development since they exhibit distinct signaling and
cell-specific localization from their homomeric counterparts. Yet, the effect
of heteromerization on the pharmacology of many GPCR homomers remains
unknown. We have undertaken the task to examine the effect of heteromeriza-
tion on Gs signaling through the adenosine 2A receptor (A2AR) and Gi signaling
through the dopamine receptor type 2 (D2R) because the A2AR-D2R heteromer
is an emerging therapeutic target for Parkinson’s disease. Previous work sug-
gests A2AR-D2R heteromerization induces reciprocal antagonism of homo-
meric signaling.
Methods:We examined the effect of heteromerization onA2AR andD2R homo-
meric signaling using electrophysiology and the Xenopus oocyte heterologous
expression system. GIRK channels were used as reporters for Gi signaling
because activation leads to direct Gbeta-gamma-mediated stimulation of the
GIRK current.We also coupled GIRK channels to Gs signaling by over express-
ingGas. Our electrophysiological assay is innovative because it allows us to opti-
mize the conditions of heteromerization. We anticipate that specific ligand
combinations targeting the A2AR-D2R heteromer will be more efficacious than
individual drug administration targeting A2AR or D2R homomers.
Results: Preliminary data have demonstrated that heteromer formation
decreases dopamine-elicited Gi signaling through the D2R and CGS-21680-
elicited Gs signaling through the A2AR. Furthermore, this reciprocal antago-
nism seemed to occur through a wide GPCR (cRNA) injection ratio. Currently,
we are examining crosstalk by assessing whether A2AR agonists or inverse
agonists will decrease or increase D2R-mediated Gi signaling through the
A2AR-D2R heteromer. Modulation of Gs signaling through the A2AR by D2R
ligands is also being examined.
Conclusions: Our electrophysiological assay demonstrates A2AR-D2R hetero-
merization induces reciprocal antagonism reducing both A2AR and D2R
signaling from that of homomeric levels.
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The dopamine D2-like receptors (D2R, D3R, and D4R), which belong to class A
Gprotein-coupled receptors, are important targets for antipsychotics. In the devel-
opment of novel antipsychotics to avoid adverse side effects, subtype-selective
dopamine receptor ligands that bind divergent secondary binding pockets
(SBP) in addition to the conserved orthosteric binding site (OBS) have been
discovered. SB269652, an allosteric modulator of D2R, consists of a tetrahydroi-
soquinoline pharmacophore bound in the OBS and an indole-2-carboxamide
moiety bound in a SBP between TM2 and TM7. This ligand was recently charac-
terized to act allosterically by a novel mechanism involving a D2R homodimer
whereby the bitopic bindingmode of SB269652 in one protomer negativelymod-
ulates the binding of an orthosteric ligand, either an agonist or an inverse agonist,
to the second protomer (Lane et al., Nature Chemical Biology, 2014).
To characterize the structural basis for the allosteric effect of SB269652,
we combined ligand modifications, complementary receptor mutagenesis, and
computational analysis, to identify the key interactions between SB269652
and D2R and the correspondingly induced conformational changes that are crit-
ical to propagate the allosteric impact across the dimer interface.We specifically
considered three pairs of SB269652 derivatives that are modified in the orthos-
teric or secondary pharmacophore, or the linker region - in each pair, the modi-
fications either retain/improve or eliminate the allosteric property. Using
molecular docking and dynamics simulations, we characterized the binding
modes of these derivatives in D2R, either in a protomer alone or in a dimer
context with an orthosteric ligand bound in the other protomer. The results of
our comparative modeling and analysis highlight the importance of thereceptor-ligand interaction formed in the SBP between Glu95(2.65) and the
indole-2-carboxamide moiety, in modulating the conformational rearrange-
ments of the dimer interface(s).
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Atypical antipsychotic drugs targeting the 5-HT2A receptor (2AR) are widely
used in the treatment of schizophrenia and psychosis. Recent studies point to a
new class of potential antipsychotic drugs targeting the metabotropic glutamate
receptor 2 (mGluR2). We recently reported that a heteromeric complex formed
between these two receptors integrates the actions of serotonergic and glutama-
tergic drugs, modulating the balance between Gi and Gq signaling in a way that
can predict the psychoactive properties of these drugs (Fribourg et al. 2011,
Cell. 147(5):1011-23). The biological relevance of the mGluR2/2AR crosstalk
was challenged by a more recent study in which co-expression of the two re-
ceptors in HEK-293 cells had no significant effect on either Gi or Gq signaling
in response to several serotonergic and glutamatergic drugs (Delille et al.,
2012, Neuropharmacology 62(7):2184-91). To address this controversy, we
generated several clones of HEK-293 cells expressing different levels of the
two receptors in the background of the G protein inwardly rectifying
GIRK1/GIRK4 channel, which can serve as a reporter for both Gi and Gq
signaling. Using the ratiometric calcium indicator Fura-2 for quantification
of Gq signaling we identified clones showing various degrees of functional
crosstalk between the two receptors (crosstalk positive clones) and clones
that were crosstalk negative. Functional crosstalk correlated with the expres-
sion levels of the two receptors, as measured by real time RT-PCR and flow-
cytometry. GIRK channel activity, measured by electrophysiology, confirmed
cross-signaling from both Gi and Gq sides in a crosstalk positive clone, but not
a crosstalk negative one. In the later, a combination of ligands targeting both
receptors was necessary in order to elicit functional crosstalk. We are currently
testing positive allosteric modulators of the mGluR2 for their ability to sup-
press Gq signaling through 2AR.
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Atypical antipsychotic drugs targeting the Gq-coupled serotonin 5-HT2A re-
ceptor (2AR) are widely used in the treatment of schizophrenia, whereas recent
studies point to a new class of potential antipsychotic drugs targeting the Gi-
coupled metabotropic glutamate 2 receptor (mGluR2). A physical and func-
tional interaction between the two receptors in cortical pyramidal neurons
has been demonstrated.
Using heterologously expressed receptors in Xenopus oocytes, we have previ-
ously shown that the heteromeric mGluR2/2AR complex integrates the actions
of serotonergic and glutamatergic ligands, modulating the balance between Gi
and Gq signaling in a way that can be used to predict the psychoactive proper-
ties of these drugs.
Selective positive allosteric modulators (PAMs) of mGluR2 that bind to the
transmembrane region of the receptor have shown efficacy in rodent models
predictive of antipsychotic activity. Here we show that the mGluR2 PAM,
LY487379 (or simply LY48) not only enhances glutamate-induced Gi
signaling but also shows crosstalk by reducing 5-HT-induced Gq signaling.
PAMs offer a promising therapeutic approach for the activation of GPCRs
because they preserve the physiologic pattern of receptor signaling and are
less likely to cause receptor desensitization and/or down regulation than syn-
thetic agonists.
2097-Pos Board B234
Assembly and Cooperativity of Metabotropic Glutamate Receptors
Josh Levitz, Reza Vafabakhsh, Shashank Bharill, Shashank Bharill,
Ehud Y. Isacoff.
UC Berkeley, Berkeley, CA, USA.
Metabotropic glutamate receptors (mGluRs) are G-protein coupled receptors
that are found throughout the nervous system where they respond to the major
excitatory neurotransmitter, glutamate, to modulate synaptic transmission and
plasticity via a variety of effectors. mGluRs are characterized by obligate
dimerization and the presence of large extracellular ligand binding domains.
In this study we used a combination of novel optical techniques to examine
Tuesday, February 10, 2015 417amGlu stoichiometry and to explore how these receptors cooperatively activate
in response to ligand binding.We first used single molecule fluorescence photo-
bleaching in live Xenopus oocytes and in receptors immobilized from mamma-
lian cell lysate to map the dimer interfaces of homo and heterodimers. This
work was complemented by experiments that use a covalently attached photo-
switchable tethered ligand (PTL) that works as an agonist to analyze the coop-
erativity that arises from ligand binding to one or both subunits within a dimer.
Finally, intersubunit FRET was used to analyze the conformational changes of
mGluRs in order to gain an integrative view of receptor assembly, structural
dynamics, and activation.
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Glycan-protein interactions are emerging as important modulators of mem-
brane protein organization and dynamics, regulating multiple cellular func-
tions. In particular, it has been postulated that glycan-mediated interactions
regulate surface residence time of glycoproteins and endocytosis. How this
precisely occurs is poorly understood. We applied a combination of super-
resolution nanoscopy and single molecule-based approaches to study the
role of glycan-based interactions on the dynamics of the glycosylated pathogen
recognition receptor DC-SIGN, at the nano- and micrometer scale. We find
that cell surface glycan-mediated interactions do not influence the nanoscale
lateral organization of DC-SIGN in nanoclusters but restrict the mobility of
the receptor to distinct micron-size membrane regions. These meso-scale re-
gions are in turn enriched by the endocytic protein clathrin, thereby dynami-
cally promoting DC-SIGN transient nano-scale arrest and interaction with
clathrin. Disruption of glycan-based connectivity leads to larger mem-
brane exploration, reduced clathrin interaction and compromised clathrin-
dependent internalization of virus-like particles. Therefore, our work uncovers
a novel mechanism through which glycan-protein interactions act as decision-
makers in fine-tuning membrane-related functions by dynamically coupling
micro- and nanoscale receptor lateral mobility, thus adding a new layer
of regulation to the hierarchical spatiotemporal organization of the cell
membrane.
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The initial arrest of platelets at a wound site requires the binding of glycopro-
tein Ib-IX-V complex (GPIb-IX-V) to the extracellular matrix protein von
Willebrand factor (VWF). Increasing forces on these bonds increases the
bond lifetime, known as a catch bond. Recently, we have shown that platelets
are able to transmit cytoskeletal forces through the GPIba subunit of GPIb-IX-
V, which binds to the A1 domain of VWF. This provides an internal force on
the bond to maintain adhesion in the absence of external forces. Integrin
engagement and force transmission are known to require receptor clustering.
We therefore investigate whether the clustering of GPIb-IX-V receptor is
needed for the transmission of cytoskeletal forces to VWF. We first examined
whether GPIb-IX-V clusters formed in spreading platelets. GPIba-positive
punctate structures were visualized by confocal microscopy and correlated
with dark regions imaged using interference reflection microscopy (IRM),
indicating that GPIb-IX-V forms adhesive contacts that are similar in size
to integrin-related focal adhesions in platelets. To investigate the effect of
ligand density on platelet spreading, we prepared molecularly-defined adhe-
sive ligand spots, which were separated 28 or 108 nm apart by nonadhesive
regions using self-assembling gold nanoparticles. These nanoparticles were
coated with A1 domain of VWF. When seeded on nanoparticles with 28 nm
spacing, platelets appeared well-spread and formed punctate adhesions. How-
ever, when seeded on 108 nm spacing, platelet adhesion was significantlyreduced and those platelets that did adhere spread poorly. These findings
demonstrate that an upper limit for ligand density exists where platelet adhe-
sion and spreading are impeded. Investigating the effects of ligand spacing
will facilitate an understanding of GPIba clustering in platelet adhesion and
spreading, thus providing insight into thrombotic diseases and congenital
bleeding disorders.
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There is increasing evidence suggesting the importance of IL-6 in oncogenesis:
it stimulates tumor cells proliferation and promotes cell survival through the
inhibition of apoptosis. IL-6 acts on a receptor complex consisting of the
cytokine-specific IL-6Ra chain and the signal-transducing gp130 subunit.
Binding of IL-6 to IL-6Ra induces dimerization of gp130 which initiates
multiple signaling cascades, including STAT3 activation.
Chelidonine, the major alkaloid component of C. majus, provokes cell death in
a variety of tumor cells, possibly through the antiapoptotic Bcl-2 protein.
Expression of Bcl-2 is upregulated by STAT3 activation, which is thought to
be responsible for IL-6-mediated survival of tumor cells.
Herein we aimed to study the effect of chelidonine on the viability of human
uveal melanoma cells as wells as its interference with the IL-6R/STAT3
signaling pathway.
Antiproliferative and cell death-inducing effects of chelidonine were assessed
by flow cytometry. The apoptotic potential of chelidonine was followed by
DNA fragmentation and PI exclusion/annexin V binding assays. Expression
of STAT3, Bcl-2 and IL-6Ra and the efficiency of STAT3 activation was
also studied by flow cytometry.
Combined analysis of cell death experiments revealed chelidonine-induced
apoptosis of UM cells. Moreover, alkaloid treatment also resulted in necrotic
cell death.
Pretreatment of cells even with sublethal doses of chelidonine led to the appear-
ance of a subpopulation with abrogated STAT3 activation upon IL-6 stimula-
tion and modified Bcl-2 expression levels. We detected cells with reduced
expression of STAT3 and IL-6Ra; however, the amount of these cells was
significantly lower than that of cells with abolished STAT3 signaling.
According to our results chelidonine exerts its effect via a STAT3-dependent
mechanism. Our findings imply the possible use of chelidonine in cancer
therapy: it can either provoke cell death or weaken the antiapoptotic machinery
of tumor cells fueled by IL-6.
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Insulin is the blood glucose-lowering hormone essential for glucose homeosta-
sis. b-Cells secrete insulin in pulses in response to glucose. Loss of the oscil-
latory nature of insulin secretion is associated with the development of type
II diabetes. Calcium is the most important trigger of insulin release even though
the exact mechanism of insulin secretion regulation by calcium is elusive.
Arachidonic acid (AA) is an essential signalling molecule involved in regula-
tion of physiological functions of many cell types. In insulin secreting pancre-
atic b-cells AA was shown to modulate calcium levels and as result to trigger
insulin secretion. However, the exact interplay between AA signalling and in-
sulin secretion is still a matter of speculation. In the present work we investi-
gated the difference of AA action at the internal membranes (IMs) and the
plasma membrane (PM) of b-cells. To perform this study, we developed a
caging group which permits localization, visualization and quantitative photo-
release of AA exclusively on the PM of living cells. We applied it in combina-
tion with a previously reported caging group used to release AA on the IMs. We
found that the release of AA on the PM and the IMs leads to a significantly
different modulation of intracellular calcium dynamics. Uncaging of AA on
the PM induces calcium oscillations in non-oscillating cells and increases the
duration of calcium transients in oscillating cells, leading to overall higher cal-
cium levels. Release of AA on the IM results in transiently or permanently
diminished calcium oscillations in b-cells and lower average calcium levels.
We attribute the observed effects to direct action of AA on Arachidonic acid
Regulated Calcium (ARC) channels localized on the PM and potentially a
negative feedback mechanism triggered by higher levels of AA at the internal
membranes.
